Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
09/02/1998 | CN1191753A Dual action 2', 5'-oligoadenylate antiviral derivatives and uses thereof |
09/02/1998 | CN1191749A Chinese herbal medicine for preventing and curing diseases of fishes and shrimps |
09/01/1998 | US5801246 Bactericides |
09/01/1998 | US5801242 Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
09/01/1998 | US5801235 Oligonucleotides with anti-cytomegalovirus activity |
09/01/1998 | US5801234 Polynucleotide encoding saliva binding protein |
09/01/1998 | US5801190 Fused pyrrolo 2,3-C! carbazole-6-ones |
09/01/1998 | US5801157 Plasmid contained in oil in water or water in oil emulsion and comprising protein, glycoprotein or peptide |
09/01/1998 | US5801018 Vaccines for Actinobacillus pleuropneumoniae |
09/01/1998 | US5801017 Production of recombinant factor Xa inhibitor of leech Hirudo medicinalis |
09/01/1998 | US5800988 Cdna libraries with nucleotide sequences coded for immunoglobulins with polypeptide chains |
09/01/1998 | US5800981 Human cytomegalovirus antigen and its use |
09/01/1998 | US5800980 Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization |
09/01/1998 | US5800822 Tandem synthetic HIV-1 peptides |
09/01/1998 | CA1340018C Monoclonal antibodies reactive with cachetin |
08/28/1998 | CA2230497A1 Novel lica |
08/28/1998 | CA2230490A1 Novel licc |
08/28/1998 | CA2230478A1 Novel licd2 |
08/28/1998 | CA2230473A1 Novel licd1 |
08/28/1998 | CA2230467A1 Novel licb |
08/27/1998 | WO1998037218A1 Hydroxyazepanes as inhibitors of glycosidase and hiv protease |
08/27/1998 | WO1998037217A1 A soluble vaccinia virus protein that binds chemokines |
08/27/1998 | WO1998037216A1 Recombinant chimeric viruses and uses thereof |
08/27/1998 | WO1998037188A1 OLIGONUCLEOTIDES SPECIFIC FOR THE marORAB OPERON |
08/27/1998 | WO1998037090A1 Antipathogenic synthetic peptides and compositions comprising them |
08/27/1998 | WO1998037089A2 Matrix derived anti-hiv peptides and transdominant proteins |
08/27/1998 | WO1998037072A1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
08/27/1998 | WO1998036779A2 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
08/27/1998 | WO1998036752A1 Methods for preventing and treating pestivirus infection and associated diseases |
08/27/1998 | WO1998036750A1 Anti-microbial product |
08/27/1998 | WO1998036741A2 Use of 2-desoxyglucose for suppressing viral transcription |
08/27/1998 | WO1998024782A3 Substituted pyrimidine compounds and their use |
08/27/1998 | WO1998021231A3 Streptococcus uberis lactoferrin-binding protein |
08/27/1998 | WO1998019997A3 Dihydropyrones with improved antiviral activity |
08/27/1998 | WO1998015295A3 Radiopharmaceuticals for imaging infection and inflammation |
08/27/1998 | WO1998006437A3 Compositions and methods for polynucleotide delivery |
08/27/1998 | CA2281524A1 Anti-microbial product |
08/27/1998 | CA2281204A1 Antipathogenic synthetic peptides and compositions comprising them |
08/27/1998 | CA2251646A1 Methods for preventing and treating pestivirus infection and associated diseases |
08/26/1998 | EP0860700A2 Use of HSV-1 UL-15 and VP5 in identifying anti-viral agents |
08/26/1998 | EP0860506A1 Human protein kinase hYAKI (HOACF 72) |
08/26/1998 | EP0860504A1 Polypeptides of feline T-cell lymphotropic lentivirus |
08/26/1998 | EP0860502A1 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor |
08/26/1998 | EP0860445A1 New nucleotide sequences for the cell cycle regulated expression of structural genes |
08/26/1998 | EP0860422A1 Derivatives of benzylidene cyclohexanone, benzylidene cyclopentanone, and benzylidene acetone and their synthesis. |
08/26/1998 | EP0859847A1 Composition and method of imparting resistivity to hiv superinfection to cells |
08/26/1998 | EP0859845A1 Novel cell surface protein compounds |
08/26/1998 | EP0859787A1 G-protein coupled receptor hnfds78 |
08/26/1998 | EP0859784A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
08/26/1998 | EP0859783A1 Process for isolating immunoglobulins in whey |
08/26/1998 | EP0859779A1 Interleukin converting enzyme and apoptosis |
08/26/1998 | EP0859771A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
08/26/1998 | EP0859631A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
08/26/1998 | EP0859629A2 Product for inhibition of attachment of h. influenzae to human cells |
08/26/1998 | EP0859628A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
08/26/1998 | EP0563093B1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
08/26/1998 | EP0558603B1 Retroviral protease inhibitors |
08/26/1998 | EP0557427B1 Human rotaviruses, vaccines and methods |
08/26/1998 | EP0531413B1 An antiviral composition containing prostratin |
08/26/1998 | CN1191572A Recombinant protein having bacteriophage endosialidase enzymatic activity |
08/26/1998 | CN1191567A Macrophage activating factors derived from cloned vitamin D binding protein |
08/26/1998 | CN1191544A Helicobacter pylori antigens and vaccine compositions |
08/26/1998 | CN1191492A Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
08/25/1998 | US5798491 Multi-mechanistic chemical cleavage using certain metal complexes |
08/25/1998 | US5798448 AL-1 neurotrophic factor antibodies |
08/25/1998 | US5798391 Viricides, antitubercular agents |
08/25/1998 | US5798365 Substituted quinoline derivatives, a process for their preparation, and their use |
08/25/1998 | US5798343 Treating gram-negative bacteria with hydrofluoric acid, hydrolyzing or metholyzing, permethylating |
08/25/1998 | US5798336 Antimicrobial peptides |
08/25/1998 | US5798265 Encoding rna complementary to message rna; antisense agents |
08/25/1998 | US5798233 Functionally active lipooligosaccharide glycosyltransferase of neisseria gonorrhea |
08/25/1998 | US5798228 Recombinant production of dog and horse type I interferons |
08/25/1998 | US5798205 Isolated protein or polypeptide; for detecting antibodies against htlv |
08/25/1998 | US5798103 Whooping cough vaccine comprising a fimbria protein |
08/25/1998 | US5798100 Multi-stage cascade boosting vaccine |
08/25/1998 | US5797906 Retrograde tissue splitter and method |
08/25/1998 | CA2224111A1 Novel compounds |
08/25/1998 | CA2107620C Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic |
08/24/1998 | CA2220855A1 Cdna clone hdpb130 that encodes a novel human 7-transmembrane receptor |
08/21/1998 | CA2223032A1 Use of hsv-1 ul-15 and vp5 in identifying anti-viral agents |
08/20/1998 | WO1998036070A1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-λB ACTIVATION |
08/20/1998 | WO1998035977A1 Benzimidazole derivatives |
08/20/1998 | WO1998035949A1 Bicyclic amino acids |
08/20/1998 | WO1998035694A2 A pharmaceutical composition for treating hepatitis b virus (hbv) infection |
08/20/1998 | WO1998035685A1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
08/20/1998 | WO1998035672A1 Pharmaceutical formulations comprising amoxocyllin and clavulanate |
08/20/1998 | WO1998035562A1 Polynucleotide vaccine formulations |
08/20/1998 | WO1998024911A3 Mutants of streptococcal toxin a and methods of use |
08/20/1998 | WO1998018931A3 Streptococcus pneumoniae polynucleotides and sequences |
08/20/1998 | WO1998014215A3 Glycoconjugates as virus cell adhesion inhibitors |
08/20/1998 | DE19705450A1 Bicyclische aromatische Aminosäuren Bicyclic aromatic amino acids |
08/20/1998 | CA2280998A1 A pharmaceutical composition for treating hepatitis b virus (hbv) infection |
08/20/1998 | CA2280857A1 Pharmaceutical formulations comprising amoxocyllin and clavulanate |
08/20/1998 | CA2280839A1 Polynucleotide vaccine formulations |
08/20/1998 | CA2280761A1 Benzimidazole derivatives |
08/19/1998 | EP0859054A1 Drug binding protein |
08/19/1998 | EP0859053A1 Novel G-protein coupled receptor (HTADX50) |
08/19/1998 | EP0858999A1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
08/19/1998 | EP0858806A1 Use of a combination of beta-sitosterol and beta-sitosterol glucoside for treating HIV infection |
08/19/1998 | EP0858453A1 5-(acetamidomethyl)-3-aryldihydrofuran-2-one and tetrahydrofuran-2-one derivatives with antibiotic activity |